抗肿瘤药物上市后药物警戒及风险管理.pdfVIP

Post-approval Risk Management in Oncology 抗肿瘤药物上市后药物警戒及风险管理 Page 2 Disclaimer /免责声明 © 2021 DIA, Inc. All rights reserved. Topics / 主题 The importance of post-approval pharmacovigilance Risk management in oncology - some points of consider • Build the ‘Safety Profile’ of an oncology drug • Risk management strategy selection Risk management lifecycle Goal of risk management 上市后药物警戒的重要性 抗肿瘤药物上市后风险管理的考虑要点 • 构建抗肿瘤药物的安全性特征 • 风险管理策略的选择 风险管理的生命周期 总结 ©